Related Experiment Videos

The effects of hepatitis B vaccination on infants born to carriers without HBe antigenemia

Acta Paediatrica Japonica : Overseas Edition
|April 1, 1989
PubMed

Insights

Hepatitis B vaccination alone may protect infants born to hepatitis B e antigen-negative mothers. Infants receiving only the Hepatitis B vaccine showed no seroconversion, unlike unvaccinated infants.

Area of Science:

  • Hepatology
  • Immunology
  • Pediatrics

Background:

  • Hepatitis B virus (HBV) infection poses a significant risk to infants born to HBsAg-positive mothers.
  • Hepatitis B e antigen (HBeAg) status of the mother is a key factor in vertical transmission risk.

Purpose of the Study:

  • To evaluate the efficacy of Hepatitis B (HB) vaccination alone in preventing HBV infection in infants born to HBeAg-negative mothers.
  • To assess the role of HB immune globulin (HBIG) in conjunction with vaccination.

Main Methods:

  • Retrospective study of 53 infants born to HBsAg-positive mothers.
  • Analysis of HBV seroconversion rates in 17 infants born to HBeAg-negative mothers based on vaccination status (HB vaccine alone vs. no vaccination).
  • Correlation analysis with HBIG administration.

Main Results:

  • None of the 6 infants receiving only HB vaccination showed seroconversion.
  • 6 out of 11 (54.5%) infants who did not receive HB vaccination showed seroconversion.
  • No significant correlation found between seroconversion and HBIG administration.

Conclusions:

  • Hepatitis B vaccination alone appears sufficient to prevent HBV infection in infants born to HBeAg-negative mothers.
  • HBIG may not be essential in this specific patient group.
  • Further prospective studies are warranted to confirm these findings.

Related Concept Videos